Treatment with Elonva should be started under the supervision of a doctor experienced in the treatment of fertility problems (pregnancy difficulties). It is available in 100 mcg / 0.5 mL and 150 mcg / 0.5 mL injection solution (pack of 1 filled syringe and 1 separate needle.
Controlled Ovarian Stimulation (EOC) for the development of multiple follicles and pregnancy in women participating in the Assisted Reproduction Technology (ART) program.
Elonva Side Effects
The most frequently reported adverse events are ovarian hyperstimulation syndrome, pain, pelvic discomfort, headache (headache), nausea (desire to vomit), fatigue (tiredness) and breast complaints (including breast tenderness), among others.
How to use Elonva
The recommended dose for women with body weight greater than or equal to 60 kg is 100 mcg single injection and for women weighing 60 kg or more, the recommended dose is 150 mcg single injection.Elonva (alfacorifolitropin) should be given as a single subcutaneous injection, preferably into the abdominal wall, during the early follicular phase of the menstrual cycle.
Elonva (alfacorifolitropin) is for single subcutaneous injection only. Additional injections of Elonva (alfacorifolitropin) should not be done within the same treatment cycle.The injection should be given by a healthcare professional (eg a nurse), the patient herself or her partner, provided they are informed by the doctor.